Your browser doesn't support javascript.
loading
First-in-Human Evaluation of 18F-PF-06445974, a PET Radioligand That Preferentially Labels Phosphodiesterase-4B.
Wakabayashi, Yuichi; Stenkrona, Per; Arakawa, Ryosuke; Yan, Xuefeng; Van Buskirk, Maia G; Jenkins, Madeline D; Santamaria, Jose A Montero; Maresca, Kevin P; Takano, Akihiro; Liow, Jeih-San; Chappie, Thomas A; Varrone, Andrea; Nag, Sangram; Zhang, Lei; Hughes, Zoë A; Schmidt, Christopher J; Doran, Shawn D; Mannes, Andrew; Zanotti-Fregonara, Paolo; Ooms, Maarten; Morse, Cheryl L; Zoghbi, Sami S; Halldin, Christer; Pike, Victor W; Innis, Robert B.
Afiliación
  • Wakabayashi Y; Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland.
  • Stenkrona P; Department of Clinical Neuroscience Psychiatry Section, Karolinska Institutet, Stockholm, Sweden.
  • Arakawa R; Department of Clinical Neuroscience Psychiatry Section, Karolinska Institutet, Stockholm, Sweden.
  • Yan X; Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland.
  • Van Buskirk MG; Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland.
  • Jenkins MD; Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland.
  • Santamaria JAM; Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland.
  • Maresca KP; Worldwide Research, Development, and Medicine, Pfizer Inc., New York, New York; and.
  • Takano A; Department of Clinical Neuroscience Psychiatry Section, Karolinska Institutet, Stockholm, Sweden.
  • Liow JS; Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland.
  • Chappie TA; Worldwide Research, Development, and Medicine, Pfizer Inc., New York, New York; and.
  • Varrone A; Department of Clinical Neuroscience Psychiatry Section, Karolinska Institutet, Stockholm, Sweden.
  • Nag S; Department of Clinical Neuroscience Psychiatry Section, Karolinska Institutet, Stockholm, Sweden.
  • Zhang L; Worldwide Research, Development, and Medicine, Pfizer Inc., New York, New York; and.
  • Hughes ZA; Worldwide Research, Development, and Medicine, Pfizer Inc., New York, New York; and.
  • Schmidt CJ; Worldwide Research, Development, and Medicine, Pfizer Inc., New York, New York; and.
  • Doran SD; Worldwide Research, Development, and Medicine, Pfizer Inc., New York, New York; and.
  • Mannes A; Anesthesia Department, NIH Clinical Center, Bethesda, Maryland.
  • Zanotti-Fregonara P; Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland.
  • Ooms M; Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland.
  • Morse CL; Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland.
  • Zoghbi SS; Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland.
  • Halldin C; Department of Clinical Neuroscience Psychiatry Section, Karolinska Institutet, Stockholm, Sweden.
  • Pike VW; Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland.
  • Innis RB; Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland; robert.innis@nih.gov.
J Nucl Med ; 63(12): 1919-1924, 2022 12.
Article en En | MEDLINE | ID: mdl-35772961
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fosfodiesterasas de Nucleótidos Cíclicos Tipo 4 / Proteínas de Neoplasias Límite: Animals / Humans Idioma: En Revista: J Nucl Med Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fosfodiesterasas de Nucleótidos Cíclicos Tipo 4 / Proteínas de Neoplasias Límite: Animals / Humans Idioma: En Revista: J Nucl Med Año: 2022 Tipo del documento: Article